Evidence-Based Medicine Guidelines
Phosphodiesterase 5 inhibitors for Raynaud's phenomenon
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phosphodiesterase 5 Inhibitors for Raynaud's Phenomenon." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon.
Phosphodiesterase 5 inhibitors for Raynaud's phenomenon. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon. Accessed November 8, 2024.
Phosphodiesterase 5 inhibitors for Raynaud's phenomenon. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon
Phosphodiesterase 5 Inhibitors for Raynaud's Phenomenon [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phosphodiesterase 5 inhibitors for Raynaud's phenomenon
ID - 1305541
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305541/all/Phosphodiesterase_5_inhibitors_for_Raynaud's_phenomenon
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
